Transcode Therapeutics

Transcode Therapeutics

Price & Volume

Stats

See more
52W Range
$2.24-$20.99
Market Cap
$2.6M
Shares Short
30,910

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$42.43

About

CEO
Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D.
CFO
Mr. Thomas A. Fitzgerald M.B.A.
Address
6 Liberty Square, Boston, MA, United States, 02109
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
12